HILDEN, Germany, and GERMANTOWN, Maryland, — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received U.S. Food and Drug Administration (FDA) approval to market the therascreen® KRAS RGQ PCR Kit (therascreen KRAS test) to provide guidance on the use of Erbitux® (cetuximab) as a treatment in patients with metastatic colorectal cancer. […]
Gaithersburg, Maryland and SEOUL, Korea, – Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, today announced that it will introduce Quantplex™ MTB/MDR/XDR Detection, a real time test that detects Mycobacterium tuberculosis and resistance mutations associated with multiple drug resistant (MDR) and extensively drug resistant (XDR) forms of M. tuberculosis at […]
Phenomenome Discoveries Inc. (“PDI”) and Polymedco Cancer Diagnostic Products LLC. (“Polymedco CDP”) are pleased to announce a commercial licensing agreement for the US market, providing rights to Polymedco to commercialize PDI’s diagnostic blood test that assesses an individual’s risk of colorectal cancer (“CRC”). Using patented technology, PDI has discovered that approximately nine out of ten […]
INDIANAPOLIS, — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch in the U.S. and Canada of the cobas p 312 pre-analytical system, a front-end automation solution that offers comprehensive, vendor-neutral sample management for labs with limited floor space. The compact, stand-alone system performs sample registration, sorting, decapping and archiving of all sample tubes—including […]
SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the appointment of Carolyn Beaver to Vice President and Chief Accounting Officer. “Carolyn’s strong background and financial acumen make her an extremely valuable complement to the Sequenom management team,” said Paul Maier, Sequenom’s Chief Financial Officer. “We […]
ALISO VIEJO, Calif.– Ambry Genetics, a global leader in genetics with a focus on clinical diagnostics and genomic services, is sponsoring the Clinical Diagnostics Conference 2012, September 27-29 at the St. Regis Monarch Beach Resort. The event will feature a keynote speech by Kevin Davies, Ph.D., Editor-in-Chief of Bio-IT World and author of The $1,000 […]
Mansfield, MA — PrimeraDx, a molecular diagnostics company, today announced that it has entered into a multi-year relationship with Eli Lilly and Company to develop diagnostic products in support of multiple clinical development programs for novel therapeutics. Under the terms of this agreement, the two companies will collaborate to develop innovative multiplex assays on PrimeraDx’s […]
SAN DIEGO, — Trovagene, Inc. (Nasdaq: TROV), a developer of trans-renal molecular diagnostics, announced that Russell Investments has added Trovagene to the Russell Microcap Index based on Russell Investments annual reconstitution of its family of U.S. indexes finalized after the close of the U.S. markets on June 22, 2012. “We are pleased to be included […]
HILDEN, Germany, and GERMANTOWN, Maryland, USA, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today unveiled an advanced initiative to enter the field of next-generation sequencing (NGS) that aims to establish these technologies as routine processes used in new areas such as clinical research and molecular diagnostics. QIAGEN is in the advanced stages of […]
REPROMEDA and BlueGnome (Brno, Czech Republic and Cambridge, UK) are pleased to announce that REPROMEDA has achieved ISO 15189 accreditation for use of BlueGnome’s 24sure platform for their laboratories in Brno, Czech Republic. REPROMEDA was founded in 1999 as a facility for reproductive medicine and assisted reproduction and was the first facility in Central and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
